1. 163 MUTATIONAL PROFILING IN CHRONIC MYELOMONOCYTIC LEUKEMIA COMPARED TO PRIMARY MYELOFIBROSIS. Issue 1 (April 2015) Authors: Santos, F. PS; Puga, R.; Helman, R.; Pereira, W.; Datoguia, T.; Lisboa, B.; Miyaji, M.; da Mata, E.; Nakashima, S.; Bello, I.; Diniz, M.; Perini, G.; Gusmao, B.; Velloso, E.; Hamerschlak, N.; Campregher, P. Journal: Leukemia research Issue: Volume 39:Issue 1(2015:Jan.) Page Start: S83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and Prognostic Features in a Series of 277 Patients with Chronic Myelomonocytic Leukemia (CMML) from South America: A Multicenter Study. (April 2017) Authors: Gonzalez, J.S.; Bestach, Y.; Arbelbide, J.; Perusini, A.; Romagnoli, C.; Fantl, D.; De Dios Soler, M.; Rossenhain, M.; Santos, I.; Lima, W. Macedo; Velloso, E.; Rocha, V.; Larripa, I.; Flores, M.G.; Belli, C. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PB1844: THROMBOTIC EVENTS DURING REMISSION INDUCTION OF ACUTE MYELOID LEUKEMIA – FREQUENCY AND RELATED FACTORS. (23rd June 2022) Authors: Silva, W.; Melo, R.; Mendes, F.; Velloso, E.; Rocha, V.; Rego, E. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1724 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Relevance of Cytogenetics in Myelodysplastic Syndrome (MDS) in the Assessment of Hematopoietic Stem Cell Transplantation (HSCT) Survival. (April 2017) Authors: Duarte, F.; Santos, T.E.J.; Korhnblitt, L.; Correa, W.; Basquiera, A.L.; Belli, C.; Funke, V.A.M.; Colturato, V.A.R.; Hamerschlak, N.; Vilela, N.C.; Silva, R.L.; Vigorito, A.C.; Paz, A.; Stevenazzi, M.; Velloso, E.; Neto, A.E. Hallack; Bettarello, G.; Lopes, L.F.; Soares, R.D.D.A.; Lemes, R.P.G. Journal: Leukemia research Issue: Volume 55(2017)Supplement 1 Page Start: S140 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Topic: AS01-Diagnosis/AS01b-Flow cytometry: IMMUNOPHENOTYPIC BONE MARROW CHARACTERISTICS IN MYELODYPLASTIC SYNDROME WITH SF3B1 MUTATION. (May 2023) Authors: Souto, E.; Bento, L.; Velloso, E.; Campregher, P.; Fernandes, L.; Nunes, V.; Bacal, N. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Topic: AS02-Epidemiology: TP53 MYELODYSPLASTIC SYNDROMES IN LATIN AMERICA. REAL WORLD DATA FROM LATIN AMERICAN MDS GROUP (GLAM). (May 2023) Authors: Boada, M.; Arbelbide, J.; Basquiera, A.; Velloso, E.; Iastrebner, M.; Catalán, A.; Grille, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Topic: AS03-Health Economics & Outcome Research/AS03a-Cost of care: ALTERNATIVE DOSING SCHEDULES OF AZACITIDINE: A REAL-WORLD COMPARATIVE STUDY ACROSS SOUTH AMERICAN CENTERS. (May 2023) Authors: Castelo, L.; Belli, C.; Buccheri, V.; Perusini, A.; Enrico, A.; Arbelbide, J.; Silva, W.; Iastrebner, M.; Gonzalez, J.; Pereyra, P.; Pereira, T.; Marchi, L.; Rocha, V.; Velloso, E. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Topic: AS07-Singular Entities/Subtypes/AS07d-MDS with ring sideroblasts: MYELOID NEOPLASMS WITH SF3B1 MUTATION: A BRAZILIAN COHORT. (May 2023) Authors: Fernandes, L.; Nunes, V.; Peonorio, P.; Cortes, L.; Rosa, S.; Silveira, C.; De Lima, L.; Campregher, P.; Velloso, E. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Topic: AS08-Treatment/AS08a-Current treatment options – Higher risk MDS: VENETOCLAX AND AZACYTIDINE IN HIGH-RISK MYELODYSPLASTIC SYNDROMES, A REAL-WORLD EXPERIENCE. LATIN-AMERICAN MDS GROUP – GLAM. (May 2023) Authors: Iastrebner, M.; Crisp, R.; Ovilla, R.; Enrico, A.; De Leon, A. Gomez; Varela, A.; Velloso, E.; Puente, A.; Duarte, F.; Gusmao, B. Moreno; Schusterschitz, S.; Wernicke, P.; Boada, M.; Pereyra, P.; Grille, S. Journal: Leukemia research Issue: Volume 128(2023)Supplement Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗